Fundraising FoxDe Novo Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Stridebiostridebio.cominSeries B · Mar 2021 · $82M
StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.
BiotechHealthtechDurham, US
Aravind Asokan(Director)inMavis Abjandje-McKenna(Director)Richard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)
Co-investorsPontifax Venture CapitalAbingworthHatteras Venture PartnersNorthpond Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.